These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparing prevalence of chronic kidney disease and its risk factors between population-based surveys in Russia and Norway. Cook S, Solbu MD, Eggen AE, Iakunchykova O, Averina M, Hopstock LA, Kholmatova K, Kudryavtsev AV, Leon DA, Malyutina S, Ryabikov A, Williamson E, Nitsch D. BMC Nephrol; 2022 Apr 14; 23(1):145. PubMed ID: 35421937 [Abstract] [Full Text] [Related]
5. Effect of adiposity on differences in carotid plaque burden in studies conducted in Norway and Russia: a cross-sectional analysis of two populations at very different risk of cardiovascular mortality. Imahori Y, Frost C, Mathiesen EB, Ryabikov A, Kudryavtsev AV, Malyutina S, Kornev M, Hughes AD, Hopstock LA, Leon DA. BMJ Open; 2020 May 06; 10(5):e036583. PubMed ID: 32381537 [Abstract] [Full Text] [Related]
6. Obesity Prevalence and Associated Socio-Demographic Characteristics and Health Behaviors in Russia and Norway. Kholmatova K, Krettek A, Leon DA, Malyutina S, Cook S, Hopstock LA, Løvsletten O, Kudryavtsev AV. Int J Environ Res Public Health; 2022 Aug 01; 19(15):. PubMed ID: 35954782 [Abstract] [Full Text] [Related]
7. Hazardous alcohol consumption and problem drinking in Norwegian and Russian women and men: The Tromsø Study 2015-2016 and the Know Your Heart study 2015-2018. Hopstock LA, Kudryavtsev AV, Malyutina S, Cook S. Scand J Public Health; 2023 Nov 01; 51(7):986-994. PubMed ID: 34965794 [No Abstract] [Full Text] [Related]
8. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Muntner P, Davis BR, Cushman WC, Bangalore S, Calhoun DA, Pressel SL, Black HR, Kostis JB, Probstfield JL, Whelton PK, Rahman M, ALLHAT Collaborative Research Group. Hypertension; 2014 Nov 01; 64(5):1012-21. PubMed ID: 25259745 [Abstract] [Full Text] [Related]
9. Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES). Kaczmarski KR, Sozio SM, Chen J, Sang Y, Shafi T. BMC Nephrol; 2019 Apr 25; 20(1):138. PubMed ID: 31023262 [Abstract] [Full Text] [Related]
11. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC. Circulation; 2011 Aug 30; 124(9):1046-58. PubMed ID: 21824920 [Abstract] [Full Text] [Related]
12. Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study. Akinyelure OP, Sakhuja S, Colvin CL, Clark D, Jaeger BC, Hardy ST, Howard G, Cohen LP, Irvin MR, Tanner R, Carey RM, Muntner P. Hypertension; 2020 Dec 30; 76(6):1953-1961. PubMed ID: 33131312 [Abstract] [Full Text] [Related]
13. What factors explain the much higher diabetes prevalence in Russia compared with Norway? Major sex differences in the contribution of adiposity. Iakunchykova O, Averina M, Wilsgaard T, Malyutina S, Kudryavtsev AV, Cook S, Wild S, Eggen AE, Hopstock LA, Leon DA. BMJ Open Diabetes Res Care; 2021 Mar 30; 9(1):. PubMed ID: 33664061 [Abstract] [Full Text] [Related]
15. Apparent Treatment Resistant Hypertension Among Stroke Survivors in Ghana. Sarfo FS, Ovbiagele B. J Stroke Cerebrovasc Dis; 2020 Dec 30; 29(12):105401. PubMed ID: 33096498 [Abstract] [Full Text] [Related]
16. Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia. Cybulsky M, Cook S, Kontsevaya AV, Vasiljev M, Leon DA. BMC Cardiovasc Disord; 2016 Jun 03; 16():122. PubMed ID: 27255373 [Abstract] [Full Text] [Related]